Literature DB >> 22298786

Role of metalloproteases in vaccinia virus epitope processing for transporter associated with antigen processing (TAP)-independent human leukocyte antigen (HLA)-B7 class I antigen presentation.

Elena Lorente1, Ruth García, Carmen Mir, Alejandro Barriga, François A Lemonnier, Manuel Ramos, Daniel López.   

Abstract

The transporter associated with antigen processing (TAP) translocates the viral proteolytic peptides generated by the proteasome and other proteases in the cytosol to the endoplasmic reticulum lumen. There, they complex with nascent human leukocyte antigen (HLA) class I molecules, which are subsequently recognized by the CD8(+) lymphocyte cellular response. However, individuals with nonfunctional TAP complexes or tumor or infected cells with blocked TAP molecules are able to present HLA class I ligands generated by TAP-independent processing pathways. Herein, using a TAP-independent polyclonal vaccinia virus-polyspecific CD8(+) T cell line, two conserved vaccinia-derived TAP-independent HLA-B*0702 epitopes were identified. The presentation of these epitopes in normal cells occurs via complex antigen-processing pathways involving the proteasome and/or different subsets of metalloproteinases (amino-, carboxy-, and endoproteases), which were blocked in infected cells with specific chemical inhibitors. These data support the hypothesis that the abundant cellular proteolytic systems contribute to the supply of peptides recognized by the antiviral cellular immune response, thereby facilitating immunosurveillance. These data may explain why TAP-deficient individuals live normal life spans without any increased susceptibility to viral infections.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22298786      PMCID: PMC3323003          DOI: 10.1074/jbc.M111.314856

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ T cells.

Authors:  L Van Kaer; P G Ashton-Rickardt; H L Ploegh; S Tonegawa
Journal:  Cell       Date:  1992-12-24       Impact factor: 41.582

2.  HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation.

Authors:  R A Henderson; H Michel; K Sakaguchi; J Shabanowitz; E Appella; D F Hunt; V H Engelhard
Journal:  Science       Date:  1992-03-06       Impact factor: 47.728

3.  Lactacystin, a novel microbial metabolite, induces neuritogenesis of neuroblastoma cells.

Authors:  S Omura; T Fujimoto; K Otoguro; K Matsuzaki; R Moriguchi; H Tanaka; Y Sasaki
Journal:  J Antibiot (Tokyo)       Date:  1991-01       Impact factor: 2.649

4.  Evolutionary families of metallopeptidases.

Authors:  N D Rawlings; A J Barrett
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

5.  Vaccinia NPH-I, a DExH-box ATPase, is the energy coupling factor for mRNA transcription termination.

Authors:  L Deng; S Shuman
Journal:  Genes Dev       Date:  1998-02-15       Impact factor: 11.361

6.  Multiple pathways are involved in the extracellular processing of MHC class I-restricted peptides.

Authors:  S Kozlowski; M Corr; M Shirai; L F Boyd; C D Pendleton; J A Berzofsky; D H Margulies
Journal:  J Immunol       Date:  1993-10-15       Impact factor: 5.422

7.  Membrane peptidases on human osteoblast-like cells in culture: hydrolysis of calcitonin and hormonal regulation of endopeptidase-24.11.

Authors:  S Howell; A M Caswell; A J Kenny; A J Turner
Journal:  Biochem J       Date:  1993-02-15       Impact factor: 3.857

8.  Interleukin-1 beta converting enzyme.

Authors:  N A Thornberry
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

9.  Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32.

Authors:  E A Slee; H Zhu; S C Chow; M MacFarlane; D W Nicholson; G M Cohen
Journal:  Biochem J       Date:  1996-04-01       Impact factor: 3.857

10.  Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin.

Authors:  G Fenteany; R F Standaert; W S Lane; S Choi; E J Corey; S L Schreiber
Journal:  Science       Date:  1995-05-05       Impact factor: 47.728

View more
  8 in total

1.  The viral transcription group determines the HLA class I cellular immune response against human respiratory syncytial virus.

Authors:  Carolina Johnstone; Elena Lorente; Alejandro Barriga; Eilon Barnea; Susana Infantes; François A Lemonnier; Chella S David; Arie Admon; Daniel López
Journal:  Mol Cell Proteomics       Date:  2015-01-29       Impact factor: 5.911

2.  A viral, transporter associated with antigen processing (TAP)-independent, high affinity ligand with alternative interactions endogenously presented by the nonclassical human leukocyte antigen E class I molecule.

Authors:  Elena Lorente; Susana Infantes; David Abia; Eilon Barnea; Ilan Beer; Ruth García; Fátima Lasala; Mercedes Jiménez; Carmen Mir; Antonio Morreale; Arie Admon; Daniel López
Journal:  J Biol Chem       Date:  2012-08-27       Impact factor: 5.157

3.  Clinical and immunological remarks about TAP deficiency.

Authors:  Jacques Zimmer; Marwan Sleiman; François Hentges; Stephan D Gadola
Journal:  J Biol Chem       Date:  2012-08-03       Impact factor: 5.157

4.  Complex antigen presentation pathway for an HLA-A*0201-restricted epitope from Chikungunya 6K protein.

Authors:  Elena Lorente; Alejandro Barriga; Juan García-Arriaza; François A Lemonnier; Mariano Esteban; Daniel López
Journal:  PLoS Negl Trop Dis       Date:  2017-10-30

Review 5.  Role of HLA-B27 in the pathogenesis of ankylosing spondylitis (Review).

Authors:  Bin Chen; Jia Li; Chongru He; Dahe Li; Wenwen Tong; Yuming Zou; Weidong Xu
Journal:  Mol Med Rep       Date:  2017-02-24       Impact factor: 2.952

6.  Immunoproteomic analysis of a Chikungunya poxvirus-based vaccine reveals high HLA class II immunoprevalence.

Authors:  Elena Lorente; Alejandro Barriga; Eilon Barnea; Concepción Palomo; Juan García-Arriaza; Carmen Mir; Mariano Esteban; Arie Admon; Daniel López
Journal:  PLoS Negl Trop Dis       Date:  2019-07-05

7.  CD69 does not affect the extent of T cell priming.

Authors:  Elisenda Alari-Pahissa; Laura Notario; Elena Lorente; Javier Vega-Ramos; Ana Justel; Daniel López; José A Villadangos; Pilar Lauzurica
Journal:  PLoS One       Date:  2012-10-30       Impact factor: 3.240

8.  Diversity of natural self-derived ligands presented by different HLA class I molecules in transporter antigen processing-deficient cells.

Authors:  Elena Lorente; Susana Infantes; Eilon Barnea; Ilan Beer; Alejandro Barriga; Noel García-Medel; Fátima Lasala; Mercedes Jiménez; Arie Admon; Daniel López
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.